135 related articles for article (PubMed ID: 31914842)
1. CD3D is associated with immune checkpoints and predicts favorable clinical outcome in colon cancer.
Yang Y; Zang Y; Zheng C; Li Z; Gu X; Zhou M; Wang Z; Xiang J; Chen Z; Zhou Y
Immunotherapy; 2020 Jan; 12(1):25-35. PubMed ID: 31914842
[No Abstract] [Full Text] [Related]
2. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.
Zhu Z; Ye W; Wu X; Lin S; Xu J; Li L; Li J; Wang H; Huang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350431
[TBL] [Abstract][Full Text] [Related]
4. Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinoma.
Shi J; Jiang D; Yang S; Sun Y; Wang J; Zhang X; Liu Y; Lu Y; Yang K
Int Immunopharmacol; 2020 Jun; 83():106402. PubMed ID: 32200154
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Analysis Reveals Characterization of Infiltrating T Cells in Moderately Differentiated Colorectal Cancer.
Yang X; Qi Q; Pan Y; Zhou Q; Wu Y; Zhuang J; Xu J; Pan M; Han S
Front Immunol; 2020; 11():620196. PubMed ID: 33584715
[TBL] [Abstract][Full Text] [Related]
6. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
7. Alternative splicing implicated in immunity and prognosis of colon adenocarcinoma.
Wu Z; Chen H; Liang Y; Luo W; Deng F; Zeng F
Int Immunopharmacol; 2020 Dec; 89(Pt B):107075. PubMed ID: 33099068
[TBL] [Abstract][Full Text] [Related]
8. IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma.
Shao YJ; Ni JJ; Wei SY; Weng XP; Shen MD; Jia YX; Meng LN
Medicine (Baltimore); 2020 Sep; 99(37):e22170. PubMed ID: 32925784
[TBL] [Abstract][Full Text] [Related]
9. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B
Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918
[TBL] [Abstract][Full Text] [Related]
10. The prognostic effect of PNN in digestive tract cancers and its correlation with the tumor immune landscape in colon adenocarcinoma.
Zhang H; Jin M; Ye M; Bei Y; Yang S; Liu K
J Clin Lab Anal; 2022 Apr; 36(4):e24327. PubMed ID: 35257416
[TBL] [Abstract][Full Text] [Related]
11. Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer.
Peng RQ; Chen YB; Ding Y; Zhang R; Zhang X; Yu XJ; Zhou ZW; Zeng YX; Zhang XS
World J Gastroenterol; 2010 May; 16(19):2428-34. PubMed ID: 20480531
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Biomarker SLCO4A1 Is Correlated with Tumor Immune Infiltration in Colon Adenocarcinoma.
Chen X; Yi G; Zhou Y; Hu W; Xi L; Han W; Wang F
Mediators Inflamm; 2023; 2023():4926474. PubMed ID: 37124063
[TBL] [Abstract][Full Text] [Related]
13. High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer.
Shi MJ; Meng XY; Wu QJ; Zhou XH
Cancer Manag Res; 2019; 11():2987-2995. PubMed ID: 31114346
[No Abstract] [Full Text] [Related]
14. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19.
Ahmadi M; Pashangzadeh S; Mousavi P; Saffarzadeh N; Amin Habibi M; Hajiesmaeili F; Rezaei N
Int Immunopharmacol; 2021 Jun; 95():107568. PubMed ID: 33765612
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
[TBL] [Abstract][Full Text] [Related]
16. Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy.
Turksma AW; Coupé VM; Shamier MC; Lam KL; de Weger VA; Belien JA; van den Eertwegh AJ; Meijer GA; Meijer CJ; Hooijberg E
Clin Cancer Res; 2016 Jan; 22(2):346-56. PubMed ID: 26420855
[TBL] [Abstract][Full Text] [Related]
17. Expression of signal transducing T-cell receptor zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer.
Kono K; Ichihara F; Iizuka H; Sekikawa T; Matsumoto Y
Int J Cancer; 1998 Oct; 78(3):301-5. PubMed ID: 9766562
[TBL] [Abstract][Full Text] [Related]
18. ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis.
Wu L; Sun S; Qu F; Liu X; Sun M; Pan Y; Zheng Y; Su G
Front Immunol; 2022; 13():829640. PubMed ID: 35774798
[TBL] [Abstract][Full Text] [Related]
19. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
20. CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer.
Yuan L; Xu J; Shi Y; Jin Z; Bao Z; Yu P; Wang Y; Xia Y; Qin J; Zhang B; Yao Q
Front Oncol; 2022; 12():913670. PubMed ID: 35719985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
